A Redox Cycling Model for the Action of Beta-adrenoceptor Agonists
Overview
Authors
Affiliations
A cyclic redox mechanism for the action of beta-adrenoceptor agonists is proposed. It has the following features: a) beta-adrenoceptor agonists act by 'reductive activation' of the beta-adrenoceptor (R); b) the redox state of R is reciprocally coupled to the redox state of the guanine nucleotide binding protein (G); c) binding of GTP to G reverses the agonist-induced alteration of the redox states of R and G; d) according to a specific version of the model the activation process involves a disulfide-thiol interchange reaction which leads to a GTP-revertible cross-linking of R and G by a disulfide bond. The way in which desensitization events may interfere with the proposed redox cycle is discussed.
Opioids stimulate sarcolemmal NAD(P)H-vanadate dehydrogenase activity.
Ventura C, Guarnieri C, Bastagli L, Caldarera C Basic Res Cardiol. 1988; 83(4):376-83.
PMID: 2903734 DOI: 10.1007/BF02005823.
Effect of thiols on beta 2-adrenoceptors in human mononuclear leucocytes.
Liebl B, Anhaupl T, Haen E, Remien J Naunyn Schmiedebergs Arch Pharmacol. 1988; 338(5):523-8.
PMID: 2854211 DOI: 10.1007/BF00179324.
In vitro effects of reactive O2 species on the beta-receptor-adenylyl cyclase system.
Schimke I, Haberland A, Will-Shahab L, Kuttner I, Papies B Mol Cell Biochem. 1992; 110(1):41-6.
PMID: 1315926 DOI: 10.1007/BF02385004.